Yesterday’s SRO Hill briefing on GLP-1 compounding was a wake-up call. Compounded GLP-1s are not just unapproved – they’re unsafe, deceptive, and dangerously unregulated. We’re not talking about innovation. We’re talking about illegal activity that puts patients’ lives and health

CMPI outlined five concrete federal actions to curb the dangers of compounded GLP-1s in our latest report and at @The Obesity Society’s recent Hill briefing. If you’re interested in learning more, you can watch the briefing here: youtube.com/watch?v=2nEIfZ…

Peter J. Pitts: My former comrade-in arms, former U.S. Surgeon General Dr. Richard Carmona sounds the alarm: CMS’s proposed expansion of competitive bidding threatens patient safety, stifles innovation, and reverses decades of policy protections. washingtontimes.com/news/2025/jul/…

“As CDER director, he has to walk a very fine line as both regulator of and colleague with drug developers,” said Peter Pitts, a former FDA associate commissioner, now co-founder of the Center for Medicine in the Public Interest. “The fact that he understands the perspective

Who pays the price when the FDA passes the buck on its obligation to enforce laws already the books? The answer is painfully familiar – patients in need of safe, tested and proven drugs. bit.ly/4m5bgZe

Much to unpack here. Initial thought -- By all means, let's incentive discontinuous innovation -- but we musn't abandon innovation of the incremental variety. fda.gov/industry/commi…

Sec. Kennedy is wasting no time reshaping vaccine policy—raising flu vaccine costs, casting doubt on MMR, revisiting the childhood vaccine schedule based on debunked claims, and pushing a vote to restrict access to MMR/chickenpox shots. And this is just the beginning.

Science & Vaccines: Kennedy's Jihad Against Thimerosal realclearhealth.com/2025/07/28/sci…

RFK Jr. said he'd follow the science as HHS.gov Secretary. But when a major study disproves his vaccine claims, he stays silent – and doubles down on discredited ideas. He must be held to his word. My latest op-ed in RealClearHealth: realclearhealth.com/articles/2025/…

PITTS: The Hidden Waste Making Healthcare More Expensive nhjournal.com/pitts-the-hidd…

Veni. Vidi. Vinay. wsj.com/articles/a-fla…

NY Nonprofit Hospitals Exploiting Tax Exemptions, Driving Up Costs: Report dcjournal.com/ny-nonprofit-h…

The GLP-1 shortage is over, but the illegal, unsafe, and venal exploitation of the American public continues. Here are five actions the FDA can take to protect patients in need of safe, tested, and approved medicines to manage chronic diseases like obesity and diabetes.

How to make other nations pay their fair share for medicines and lower costs to Americans. publichealth.realclearjournals.org/perspectives/2… #realclearjournals

FDA Inaction on GLP-1 Compounding is Putting Patients at Risk | Drugwonks drugwonks.com/blog/fda-inact…

RFK Jr wants us to ask questions – the best science starts with curiosity. But when Secretary Kennedy questions a legitimate, high-quality study because it challenges his agenda, he undermines the future of health and evidence-based research. reuters.com/business/healt… Michael Erman

U.S. warning on use of ‘march-in’ rights against Harvard seems like distant threat for pharma statnews.com/pharmalot/2025… via STAT